AbbVie Inc. — insider transactions
5 transactions on record · ABBV · CIK 1551152
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
5
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$0
Sold, 3m
$10.8M
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$8.2M
2026-08-14
Director share, 12m
40.0%
of transactions where role is stated
Current run
5 sells
consecutive same-direction transactions
Net 3m flow
-$10.8M
purchases minus sales
Total on record
5
Transactions
5 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-09-30 | 2 | Quaggin Susan E | Director | Grant or award | 59 | $261.59 | $15.4K | filing |
| 2026-10-02 | 2026-09-30 | 2 | RAPP EDWARD J | Director | Grant or award | 129 | $261.59 | $33.7K | filing |
| 2026-08-18 | 2026-08-14 | 4 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Exercise of derivative | 32,710 | $0.00 | — | filing |
| 2026-08-18 | 2026-08-14 | 4 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Exercise of derivative | 32,710 | $79.02 | $2.6M | filing |
| 2026-08-18 | 2026-08-14 | 4 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Open market sale | 32,710 | $250.00 | $8.2M | filing |